Short answer: USP <800> recommends environmental wipe sampling for hazardous drug (HD) surface contamination at least every six months, with no established "safe" contamination level — results must simply be undetectable.[1][4] Because there's no tolerance for ambiguity, every wipe sample needs precise, structured documentation. A digital sampling plan — not a clipboard — is what keeps that documentation defensible when a surveyor asks for it.
What does USP <800> actually require for surface sampling?
USP <800> recommends, though doesn't strictly mandate, routine environmental wipe sampling for hazardous drug surface residue — typically established at baseline, then repeated at least every six months, or more often based on compounding volume.[1][4]
- Common marker HDs include cyclophosphamide, ifosfamide, methotrexate, fluorouracil, and platinum-containing drugs.[4]
- Sampling should cover the interior of the primary engineering control (C-PEC) and equipment inside it, plus other high-contact surfaces.[3][4]
- There's currently no regulatory "acceptable" contamination level — the standard is essentially undetectable.[1][4]
That last point is why documentation quality matters so much: with no numeric tolerance to hide behind, the defensibility of the *process* is what protects a facility.
Why do paper notes fail during wipe sampling?
Because a valid, repeatable wipe sample depends on precise, consistent metadata — exactly what a clipboard tends to lose under time pressure.
- Location tracking: samples should be taken from the same spots each round so trending is meaningful — that only works if locations are documented precisely, not "same as usual."[3]
- Surface area: wipe area (commonly measured in cm²) needs to be recorded accurately for lab reporting to be interpretable.
- Chain of custody: kits need to be logged, sealed, and tracked from swab to lab result.
- Equipment IDs: which C-PEC, which serial number, matters when results need to be traced back to a specific hood.
Miss one field in the field, and the sample may be unusable — meaning a return trip, a delayed report, or a compliance gap nobody catches until the next survey.
What should a digital HD sampling plan capture?
At minimum, each wipe sample record should include:
- Date, time, and exact sample location (with a consistent naming/location convention across rounds)
- Surface area sampled
- The C-PEC or equipment identifier
- Marker drug(s) being tested
- Kit lot number and chain-of-custody detail
- The technician who collected the sample
- Any PPE or containment deviations observed during collection
How myIH supports USP <800> sampling documentation
myIH is industrial hygiene field-note software that structures observations at the point of collection — which is exactly where HD wipe sampling documentation tends to break down.
- Guided, structured fields mean a technician can't submit a sample record with a missing location, surface area, or equipment ID
- Consistent location tracking across sampling rounds, so trending data actually compares apples to apples
- One-click export to Excel or PDF field notes when a pharmacy director or surveyor needs the record
- Real-time oversight of what's being documented on-site, so gaps get caught before the technician leaves the compounding area
To be clear on scope: myIH structures and exports your team's field observations — it doesn't perform lab analysis or interpret wipe sample results. It makes sure the sampling event itself is captured completely and consistently.
Frequently asked questions
At least every six months as a general benchmark, with more frequent sampling based on compounding volume and facility risk assessment.
No. There is currently no established standard for acceptable HD surface contamination levels — the goal is undetectable results.
Precise sample location, surface area, equipment identifier, marker drug tested, chain-of-custody detail, and the technician who collected it.
References
- "USP <800> FAQs." United States Pharmacopeia, 21 Jan. 2026
- "Complying with the Surface Sampling Requirements of USP 800." AIHA, 14 Mar. 2024
- "General Chapter <800> Hazardous Drugs—Handling in Healthcare Settings." United States Pharmacopeia
- "USP <800> FAQs." United States Pharmacopeia (Utah DOPL archive), 1 Nov. 2023
- "The Complete Guide to Hospital Pharmacy USP 797/800 Cleaning." NanoClean Decon, 30 Jan. 2026
Curious how myIH would fit your workflow?
Fifteen minutes, your process, and a clear picture of the field-to-report flow.
Book a demo with Sam